🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

SCENAR Therapy in Chronic Non-specific Neck Pain

RecruitingNAAges 18 Years - 80 YearsAllHopital Foch
NCT07742228 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Shifting away from a medication-centered approach is a major public health priority, particularly in chronic pain management, where non-pharmacological therapies are recommended despite barriers such as limited evidence and low prescriber awareness. SCENAR (Self-Controlled Energo-Neuro Adaptive Regulation), an electrotherapy device, lacks robust randomized controlled trial data. A prior study showed effects in both active and placebo groups after a single session, supporting further investigation. This study aims to assess whether repeated SCENAR sessions improve disability, mobility, and pain in patients with chronic neck pain.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Male or female participants aged 18 years or older * Patients with chronic non-specific cervical spine pain, including cervicobrachial neuralgia, persisting for at least 3 months, with no identifiable underlying cause requiring specific treatment. * Patients who attended a pain clinic consultation or were referred to a pain specialist during hospitalization. * Neck Disability Index (NDI) score of at least 30% (≥15 points). * Written informed consent provided prior to study participation. * Patient affiliated to a national health insurance Exclusion Criteria: * Pregnant women * Skin conditions preventing SCENAR use (wounds, recent scars, skin infections) * Initiation or change of analgesic treatment within 15 days prior to inclusion or during the study * Cervical pain related to inflammatory (spondyloarthropathy, rheumatoid arthritis, chondrocalcinosis), traumatic (fractures, dislocations), tumor-related (metastases, myeloma), infectious (spondylodiscitis), or neurological (intramedullary or posterior fossa tumor) causes * Previous SCENAR or ECOMODYN session * Implanted pacemaker or defibrillator * Inability to understand French * Adults under legal protection * Individuals deprived of liberty or under guardianship
💊

What it tests

  • Active SCENAR device therapy
  • Sham SCENAR device Therapy
📍

Where

1 site
Hôpital Foch
Suresnes, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy